Literature DB >> 7559112

p185neu is expressed in yolk sac during rat postimplantation development.

V Knezevic1, R Spaventi, L Poljak, N Slade, A Svajger, K Pavelic.   

Abstract

We have shown that the neu oncogene product (p185neu) is not present in the rat embryo before organogenesis. However, coincident with the onset of organogenesis, p185neu was detected in neural and connective tissue as well as in the secretory epithelium as was described by Kokai et al. (1987). In addition, p185neu is also expressed in the rat visceral yolk sac (VYS) endodermal cells but not in the mesenchymal and mesothelial layers of the same structure nor in the amnion. The first detectable sign of p185neu expression in VYS was found at d 11 of gestation and the levels of protein increased towards the end of pregnancy. In the yolk sac carcinoma (YSC), which is considered to be the malignant counterpart of the rat yolk sac, p185neu was observed only within columnar epithelial cells (the visceral component of the neoplasm) while parietal endoderm-like cells were devoid of detectable protein. From d 9 of pregnancy up to delivery some of the trophoblastic giant cells also showed a faint to moderate immunoreactivity. Results are presented which would indicate a possible role of p185neu in rat embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7559112      PMCID: PMC1166826     

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  18 in total

Review 1.  Development, morphology, and function of the yolk-sac placenta of laboratory rodents.

Authors:  W P Jollie
Journal:  Teratology       Date:  1990-04

2.  Stage- and tissue-specific expression of the neu oncogene in rat development.

Authors:  Y Kokai; J A Cohen; J A Drebin; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  c-erbB-2 oncoprotein expression in primary human tumors.

Authors:  A McCann; P A Dervan; P A Johnston; W J Gullick; D N Carney
Journal:  Cancer       Date:  1990-01-01       Impact factor: 6.860

4.  Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

Authors:  R Lupu; R Colomer; G Zugmaier; J Sarup; M Shepard; D Slamon; M E Lippman
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

5.  An electron microscopic visualization of transport across rat visceral yolk sac.

Authors:  R O Lambson
Journal:  Am J Anat       Date:  1966-01

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  c-erbB-2/neu in colorectal carcinoma: a potential prognostic value?

Authors:  S Kapitanović; R Spaventi; B Kusić; K Pavelić
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

8.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

Authors:  L Coussens; T L Yang-Feng; Y C Liao; E Chen; A Gray; J McGrath; P H Seeburg; T A Libermann; J Schlessinger; U Francke
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

9.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

10.  Pattern of expression of c-erbB-2 oncoprotein in human fetuses.

Authors:  P Quirke; A Pickles; N L Tuzi; O Mohamdee; W J Gullick
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.